International comparisons in valuing EQ-5D health states: a review and analysis.
about
Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for ArthriHealth utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden.Quantifying quality of life and disability of patients with advanced schistosomiasis japonica.International comparison of experience-based health state values at the population level.Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population.How is the most severe health state being valued by the general population?EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approachComparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.A potential gender bias in assessing quality of life - a standard gamble experiment among university studentsA critical re-evaluation of the regression model specification in the US D1 EQ-5D value functionAn analysis of Euroqol EQ-5D and Manchester Oxford Foot Questionnaire scores six months following podiatric surgeryImpact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancerImpact of anxiety symptoms on outcomes of depression: an observational study in Asian patients.Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.Swedish experience-based value sets for EQ-5D health states.Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US.Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.Sourcing quality-of-life weights obtained from previous studies: theory and reality in Korea.Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.EQ-5D in Central and Eastern Europe: 2000-2015.Associations between living arrangements and health-related quality of life of urban elderly people: a study from China.Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.Factors associated with and impact of pain persistence in Asian patients with depression: a 3-month, prospective observational study.Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population.Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?An Australian discrete choice experiment to value eq-5d health states.A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA.A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.Development of an EORTC-8D utility algorithm for Sri Lanka.Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.Health-related quality of life in patients with acute coronary syndromes and treated with ticagrelor or clopidogrel.Australian health-related quality of life population norms derived from the SF-6D.Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.
P2860
Q31043286-DC8DEE42-55B8-41F1-BC4F-8FEA9CE448D6Q33742403-7835F5F5-214F-47A9-922A-9E70823CCAEDQ33831770-9643DF59-6A07-4EFA-9578-280650B8D6DAQ33883700-4D242C0A-1E92-4F34-9547-832929990873Q34304052-0815476D-D1B0-4A99-B54A-EDF4514EA7D4Q34416777-92CDC668-51BC-41C8-96E2-EA2FD14966F8Q34443764-CC379670-FB2B-47B7-81DE-1B547391D6C9Q34488943-7E8C58FE-9026-4DC3-B36B-8F5296E65A87Q34633630-BCB835C7-AB22-4658-BC6C-68CAB360B9EAQ35560401-32089FCF-29AE-4B1B-8514-27EA4914BD06Q35771943-B112AAEA-7311-43B6-9AF5-3426097919C7Q36373629-A9D4D7A6-CC51-4549-83D3-BC9F2CE98651Q36394607-962302C7-6F9F-4365-BC85-FFBC376C156DQ36802781-696C04D5-AB2F-4656-ABD1-839CC7D0FB83Q36957237-99991853-7430-4397-97E6-6555E698C4B5Q36968664-ADF84E00-B03F-4F45-9674-9B884CFD4D63Q37108382-599A11D1-7697-4E39-865F-7CDE619D4662Q37153727-EC377683-C009-4A06-B785-A58B072A14BBQ37666482-1F85A21E-9117-4448-B3D7-BDC5C2FFDF5DQ37710146-7FDA6B9A-164B-4295-8834-86488436C3FCQ38074370-DAC0B0B9-7A56-424E-BAAF-50959F18D883Q38191873-EB7CCA3A-2AC0-4CB7-A482-D57B8516F27CQ38254034-4B33E1A6-17EC-4710-BB6E-5E28217188F7Q38617304-5A5DE53F-C7B9-4B81-BFBA-840EB61BF47EQ38912637-D09A53A8-08C3-4143-B57E-5B43217CC1FBQ39833123-AA8F2C48-1D6E-4F3C-8363-A190779C5299Q40427202-938D3113-6039-4B57-A694-D874592ABAD4Q40515464-6374671D-EBD8-4054-AE69-400F8E5FBF4FQ40771894-B184553F-6806-4A13-BEA5-CA5607CDDD5EQ40874960-7A3C2C22-41AA-4D0F-91BD-C54FA04B0898Q41757841-35FB6649-5366-4EE6-9920-40F1080EF868Q43891957-C27B2765-A8CE-4183-8A33-B830B1E542CFQ43974817-6D0F61BD-36F8-466B-8CB7-F9A70BE3A799Q44188764-31FD4EA4-8A21-45A8-93B5-7DCBFADE0D2AQ44572362-C09AAA3A-B046-4460-9941-9C2A0379A769Q44676654-0C457773-6492-4200-A886-EED9D62CABD7Q45689360-E02D8692-40CB-438B-9F58-1FA4F74AAEB7Q45880249-A5793218-1060-4517-B3C4-E30669B6A627Q46801683-6355F98E-E4E2-478E-9877-91863349FF26Q47261501-C48C9C45-CF03-4ED6-B769-EB4ACF771A9C
P2860
International comparisons in valuing EQ-5D health states: a review and analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
International comparisons in valuing EQ-5D health states: a review and analysis.
@en
International comparisons in valuing EQ-5D health states: a review and analysis.
@nl
type
label
International comparisons in valuing EQ-5D health states: a review and analysis.
@en
International comparisons in valuing EQ-5D health states: a review and analysis.
@nl
prefLabel
International comparisons in valuing EQ-5D health states: a review and analysis.
@en
International comparisons in valuing EQ-5D health states: a review and analysis.
@nl
P2093
P1433
P1476
International comparisons in valuing EQ-5D health states: a review and analysis.
@en
P2093
Deborah Street
Madeleine King
Paula Cronin
Richard Norman
P304
P356
10.1111/J.1524-4733.2009.00581.X
P577
2009-08-20T00:00:00Z